Lead, Industrial, Whole Blood
Also known as: LEAD-IND
Use
This test is recommended for the assessment of industrial lead exposure in adults and provides exposure guidance in accordance with OSHA regulations. It aids in evaluating occupational exposure to lead and ensures compliance with safety standards, helping in the medical management and monitoring of individuals at risk for lead poisoning.
Special Instructions
For the assessment of lead exposure in a non-occupational setting, the test Lead, Whole Blood (Venous) (0020098) is preferred. Collect from patients aged 16 years or older. Use only royal blue (K2EDTA), royal blue (NaHep), or tan (K2EDTA) tubes that are certified to be trace element free to avoid contamination.
Limitations
Elevated results may be due to skin- or collection-related contamination, including the use of tubes not certified as trace element free. Confirmation with a second specimen in a certified tube is recommended if contamination is suspected. The test's performance characteristics were determined by ARUP Laboratories and it has not been cleared or approved by the FDA. It is intended for use in a CLIA-certified laboratory for clinical purposes.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 29763-0
- 2895-1
- 77307-7
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3 or 6 mL (royal blue), 3 mL (tan)
Minimum Volume
0.5 mL
Container
Royal blue (K2EDTA or NaHep), tan (K2EDTA)
Patient Preparation
Collect from patient aged 16 years or older.
Causes for Rejection
Serum. Specimens in tubes other than Royal blue(K2EDTA), Royal blue (NaHep), or tan (K2EDTA). Hemolyzed or clotted specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 hours |
| Refrigerated | 5 weeks |
| Frozen | Unacceptable |